<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-29T22:51:34Z</responseDate><request verb="GetRecord" identifier="oai:repisalud.isciii.es:20.500.12105/17289" metadataPrefix="mets">https://repisalud.isciii.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:repisalud.isciii.es:20.500.12105/17289</identifier><datestamp>2024-11-28T15:18:26Z</datestamp><setSpec>com_20.500.12105_15322</setSpec><setSpec>com_20.500.12105_2051</setSpec><setSpec>col_20.500.12105_16927</setSpec></header><metadata><mets xmlns="http://www.loc.gov/METS/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" ID="&#xa;&#x9;&#x9;&#x9;&#x9;DSpace_ITEM_20.500.12105-17289" TYPE="DSpace ITEM" PROFILE="DSpace METS SIP Profile 1.0" xsi:schemaLocation="http://www.loc.gov/METS/ http://www.loc.gov/standards/mets/mets.xsd" OBJID="&#xa;&#x9;&#x9;&#x9;&#x9;hdl:20.500.12105/17289">
   <metsHdr CREATEDATE="2026-04-30T00:51:34Z">
      <agent ROLE="CUSTODIAN" TYPE="ORGANIZATION">
         <name>Repisalud</name>
      </agent>
   </metsHdr>
   <dmdSec ID="DMD_20.500.12105_17289">
      <mdWrap MDTYPE="MODS">
         <xmlData xmlns:mods="http://www.loc.gov/mods/v3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
            <mods:mods xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Sanchez-Marin, Laura</mods:namePart>
               </mods:name>
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Pavón, Francisco-Javier</mods:namePart>
               </mods:name>
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Decara, Juan</mods:namePart>
               </mods:name>
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Suarez, Juan</mods:namePart>
               </mods:name>
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Gavito, Ana</mods:namePart>
               </mods:name>
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Castilla-Ortega, Estela</mods:namePart>
               </mods:name>
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Rodriguez de Fonseca, Fernando</mods:namePart>
               </mods:name>
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Serrano, Antonia</mods:namePart>
               </mods:name>
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">authoraffiliation</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Unidad de Gestion Clinica de Salud Mental, Instituto de Investigacion Biomedica de Malaga, Hospital Regional Universitario de Malaga, Universidad de Malaga, Malaga, Spain.</mods:namePart>
               </mods:name>
               <mods:extension>
                  <mods:dateAccessioned encoding="iso8601">2024-01-23T20:12:27Z</mods:dateAccessioned>
               </mods:extension>
               <mods:extension>
                  <mods:dateAvailable encoding="iso8601">2024-01-23T20:12:27Z</mods:dateAvailable>
               </mods:extension>
               <mods:originInfo>
                  <mods:dateIssued encoding="iso8601">2017-02-07</mods:dateIssued>
               </mods:originInfo>
               <mods:identifier type="doi">10.3389/fnbeh.2017.00015</mods:identifier>
               <mods:identifier type="e-issn">1662-5153</mods:identifier>
               <mods:identifier type="journal">Frontiers in Behavioral Neuroscience</mods:identifier>
               <mods:identifier type="other">http://hdl.handle.net/10668/2669</mods:identifier>
               <mods:identifier type="pubmedID">28223925</mods:identifier>
               <mods:identifier type="uri">http://hdl.handle.net/20.500.12105/17289</mods:identifier>
               <mods:abstract>Intermittent alcohol exposure is a common pattern of adolescent alcohol use that can lead to binge drinking episodes. Alcohol use is known to modulate the endocannabinoid system (ECS), which is involved in neuronal communication, neuroplasticity, neuroinflammation and behavior. Adolescent male Wistar rats were exposed to 4-week intermittent alcohol intoxication (3 g/kg injections for 4 days/week) or saline (N = 12 per group). After alcohol deprivation, adult rats were assessed for emotionality and cognition and the gene expression of the ECS and other factors related to behavior and neuroinflammation was examined in the brain. Alcohol-exposed rats exhibited anxiogenic-like responses and impaired recognition memory but no motor alterations. There were brain region-dependent changes in the mRNA levels of the ECS and molecular signals compared with control rats. Thus, overall, alcohol-exposed rats expressed higher mRNA levels of endocannabinoid synthetic enzymes (N-acyl-phosphatidylethanolamine phospholipase D and diacylglycerol lipases) in the medial-prefrontal cortex (mPFC) but lower mRNA levels in the amygdala. Furthermore, we observed lower mRNA levels of receptors CB1 CB2 and peroxisome proliferator-activated receptor-α in the striatum. Regarding neuropeptide signaling, alcohol-exposed rats displayed lower mRNA levels of the neuropeptide Y signaling, particularly NPY receptor-2, in the amygdala and hippocampus and higher mRNA levels of corticotropin-releasing factor in the hippocampus. Additionally, we observed changes of several neuroinflammation-related factors. Whereas, the mRNA levels of toll-like receptor-4, tumor necrosis factor-α, cyclooxygenase-2 and glial fibrillary acidic protein were significantly increased in the mPFC, the mRNA levels of cyclooxygenase-2 and glial fibrillary acidic protein were decreased in the striatum and hippocampus. However, nuclear factor-κβ mRNA levels were lower in the mPFC and striatum and allograft inflammatory factor-1 levels were differentially expressed in the amygdala and hippocampus. In conclusion, rats exposed to adolescent intermittent alcohol displayed anxiety-like behavior and cognitive deficits in adulthood and these alterations were accompanied by brain region-dependent changes in the gene expression of the ECS and other signals associated with neuroinflammation and behavior. An intermittent adolescent alcohol exposure has behavioral and molecular consequences in the adult brain, which might be linked to higher vulnerability to addictive behaviors and psychopathologies.</mods:abstract>
               <mods:language>
                  <mods:languageTerm authority="rfc3066">eng</mods:languageTerm>
               </mods:language>
               <mods:accessCondition type="useAndReproduction"/>
               <mods:subject>
                  <mods:topic>Rats</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Intermittent alcohol</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Adolescence</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Endocannabinoid system</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Neuroinflammation</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Anxiety</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Brain</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Recognition memory</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Adolescente</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Intoxicación alcohólica</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Aloinjertos</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Amígdala del cerebelo</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Animales</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Ansiedad</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Conducta adictiva</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Borrachera</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Cognición</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Hormona liberadora de corticotropina</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Ciclooxigenasa 2</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Endocannabinoides</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Etanol</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Proteína ácida fibrilar de la glía</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Hipocampo</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Humanos</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Lipoproteína lipasa</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Plasticidad neuronal</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Neuropéptido Y</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>PPAR alfa</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Fosfatidiletanolaminas</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Fosfolipasa D</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Corteza prefrontal</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>ARN mensajero</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Ratas wistar</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Receptor cannabinoide CB1</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Receptor cannabinoide CB2</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Receptor Toll-Like 4</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Factor de necrosis tumoral alfa</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Consumo de alcohol en menores</mods:topic>
               </mods:subject>
               <mods:titleInfo>
                  <mods:title>Effects of Intermittent Alcohol Exposure on Emotion and Cognition: A Potential Role for the Endogenous Cannabinoid System and Neuroinflammation</mods:title>
               </mods:titleInfo>
               <mods:genre>research article</mods:genre>
            </mods:mods>
         </xmlData>
      </mdWrap>
   </dmdSec>
   <structMap LABEL="DSpace Object" TYPE="LOGICAL">
      <div TYPE="DSpace Object Contents" ADMID="DMD_20.500.12105_17289"/>
   </structMap>
</mets></metadata></record></GetRecord></OAI-PMH>